{"groups":[{"description":"PCI-32765; ibrutinib\n\nPCI-32765: Taken orally, once daily in the morning","id":"FG000","title":"Treatment Arm"}],"periods":[{"milestones":[{"achievements":[{"groupId":"FG000","numSubjects":"63"}],"type":"STARTED"},{"achievements":[{"groupId":"FG000","numSubjects":"63"}],"type":"COMPLETED"},{"achievements":[{"groupId":"FG000","numSubjects":"0"}],"type":"NOT COMPLETED"}],"title":"Overall Study"}]}